decisionhealth Newsletters, Coder Pink Sheets - 2003 Issue 12 (December)
CMS to pay for non-guaiac FOBT
Subscribe or sign in to view the full article.
Article Overview
This article covers a CMS decision memo signaling positive coverage for non-guaiac fecal occult blood testing, with context on why the change mattered for colorectal cancer screening. It is relevant to coders, billing staff, and clinicians who work with preventive screening and laboratory test reporting, and it discusses the general coding environment around fecal occult blood testing without providing full premium-level guidance.
Why This Topic Matters
Coverage changes for screening tests can affect claim payment, patient access, and code selection workflows. Understanding the policy context helps coding professionals anticipate how Medicare and other payers may handle related laboratory services.
What You Will Learn
- The CMS coverage context for non-guaiac fecal occult blood testing
- How the article frames the distinction between screening and non-screening fecal occult blood testing
- The code landscape referenced for fecal occult blood tests at the time of publication
- Why a coverage decision can lead to coding and reimbursement changes
Who Should Read This
- Medical coders
- Billing staff
- Compliance professionals
- Primary care practices
- Obstetrics and gynecology practices
- Laboratory billing teams
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com